[34] [50] [48] [40] (NGT) [42] [35] [55] [44] (NGT and IGT) [28] (in obese only)
[26] (BA > WE at 30 mins, but no difference in total iAUC) [31] [40] (IGT and T2D) [59] [60] [27] [36] (IFG/IGT) [37] (IFG/IGT) [38] (T2D) [30] (T2D) [28] (in lean only) [29]
NGT and nondiabetic subjects, unless otherwise specified. Cumulative fasting, oral, and IV refer to the total number of participants (BA and WE) in the studies using fasting measures, oral nutrient stimulation, and intravenous glucose stimulation techniques, respectively (note that each study may be presented in more than one category). BA: black African; WE: white European; NGT: normal glucose tolerance; IFG: impaired fasting glucose; IGT: impaired glucose tolerance; T2D: type 2 diabetes.